Press Releases Ondine Biomedical Inc.

Equities

OBI

CA68234M2058

Market Closed - London S.E. Other stock markets 11:35:29 2024-06-10 am EDT			5-day change	1st Jan Change
7.25 ^GBX	0.00%		-13.69%	-17.14%

Jun. 07	Ondine Biomedical loss narrows as revenue soars 88% in 2023	AN
Jun. 07	AIM WINNERS & LOSERS: Corcel receives approvals for data acquisition	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Ondine Biomedical - Corporate and Trading Update	Apr. 25	AQ
Ondine Biomedical achieves milestone with NHS trust's adoption of Steriwave	Mar. 27	AQ
Ondine Biomedical Inc. - First commercial adoption of Steriwave by the NHS	Mar. 26	AQ
Ondine Biomedical - Appointment of new Chief Financial Officer	Jan. 17	AQ
Ondine Biomedical Inc. - Photodisinfection recommended as Standard of Care	Nov. 17	AQ
Ondine Biomedical’s nasal photodisinfection named as leading photonics biomedical technology for its potential to safely combat AMR	Nov. 13	BU
Ondine BiomedicalÃ¢€™s Steriwave platform seeing strong adoption	Nov. 06	AQ
Ondine BiomedicalÃ¢€™s Steriwave nasal photodisinfection platform now used across Canada	23-10-26	AQ
Ondine Biomedical shares potential impact of photodisinfection study on public health and safety	23-05-01	AQ
Ondine Biomedical reports photodisinfection is highly effective against key food-borne pathogens	23-04-20	BU
Ondine Biomedical shares Ottawa Hospital study on Steriwave nasal photodisinfection helping patients	23-03-09	AQ
Ondine Biomedical Inc. - Ottawa hospital presents Steriwave study results	23-03-06	AQ
Ondine Biomedical’s Nasal Photodisinfection Reduces Hospital Length of Stay, Readmissions and Antibiotic Use in Substantial Study at Major Ottawa Hospital	23-03-03	BU
Ondine's APDT reduces SARS-CoV-2 infectivity	23-02-01	AQ
Ondine’s nasal photodisinfection therapy (APDT) improves short-term and long-term immune response while significantly reducing SARS-CoV-2 infectivity	23-01-31	BU
Photodisinfection Found to Eradicate Biofilms Associated with Periprosthetic Joint Infections	23-01-17	AQ
Food Processing Plant Sees Huge Reduction in Employee COVID-19 Rates After Using Ondine Biomedical’s Nasal Photodisinfection	22-11-08	BU
Ondine Biomedical reports successful topline data from Phase 2 nasal photodisinfection trial	22-09-06	AQ
Nature publication reports that Ondine's nasal antimicrobial photodynamic disinfection therapy suppresses SARS-CoV-2 in COVID-19 patients	22-08-31	AQ
Ondine Biomedical completes patient recruitment for US Phase II nasal photodisinfection trial	22-08-08	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ondine Biomedical Inc.

Equities

OBI

CA68234M2058

Press Releases

Filters